Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 410 participants.
Also called NCT05305612
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 410 participants
- Registry
-
NCT05305612
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT05305612. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-13 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
- Acronym
- STOP CLOT
- Condition
- Mitral Regurgitation
- Condition
- Atrial Fibrillation
- Condition
- Anticoagulation
- Intervention (Other)
- early anticoagulation
- Intervention (Other)
- late anticoagulation
- Lead sponsor
- National Institute of Cardiology, Warsaw, Poland
- Collaborator
- Medical Research Agency, Poland
- Collaborator
- Soft Communication, Poland
Record details
- Record id
cardio:ct-nct05305612- Content hash
814c5107773f34f4f5b7015e09814b88ccc3bc8eccb5b787e2435fc70664791c